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Abstract
Background: CD55 (decay-accelerating factor) is a complement-regulatory protein highly expressed on fibroblast-like
synoviocytes (FLS). CD55 is also a ligand for CD97, an adhesion-type G protein-coupled receptor abundantly present on
leukocytes. Little is known regarding the regulation of CD55 expression in FLS.
Methods: FLS isolated from arthritis patients were stimulated with pro-inflammatory cytokines and Toll-like receptor (TLR)
ligands. Transfection with polyinosinic-polycytidylic acid (poly(I:C)) and 59-triphosphate RNA were used to activate the
cytoplasmic double-stranded (ds)RNA sensors melanoma differentiation-associated gene 5 (MDA5) and retinoic acid-
inducible gene-I (RIG-I). CD55 expression, cell viability, and binding of CD97-loaded beads were quantified by flow
cytometry.
Results: CD55 was expressed at equal levels on FLS isolated from patients with rheumatoid arthritis (RA), osteoarthritis,
psoriatic arthritis and spondyloarthritis. CD55 expression in RA FLS was significantly induced by IL-1b and especially by the
TLR3 ligand poly(I:C). Activation of MDA5 and RIG-I also enhanced CD55 expression. Notably, activation of MDA5 dose-
dependently induced cell death, while triggering of TLR3 or RIG-I had a minor effect on viability. Upregulation of CD55
enhanced the binding capacity of FLS to CD97-loaded beads, which could be blocked by antibodies against CD55.
Conclusions: Activation of dsRNA sensors enhances the expression of CD55 in cultured FLS, which increases the binding to
CD97. Our findings suggest that dsRNA promotes the interaction between FLS and CD97-expressing leukocytes.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory autoim-
mune disease of the joints that is characterized by a marked
thickening of the synovium due to neovascularization, fibroblast
proliferation, and the recruitment of macrophages and other
immune cells [1]. The local production of enzymes and cytokines,
and the activation of osteoclasts cause cartilage degradation and
bone erosion, finally leading to joint destruction and functional
disability.
Fibroblast-like synoviocytes (FLS) are unique cells of mesen-
chymal origin that constitute the intimal lining, which comprises
2–3 cell layers in normal conditions but can increase up to 15
layers in RA [2–4]. Due to the border position between synovial
tissue and synovial fluid, FLS obtain signals from both compart-
ments and affect synovial tissue homeostasis in many ways.
Moreover, it is increasingly appreciated that FLS contribute to the
pathogenesis of RA by regulating inflammatory processes and,
more directly, by eroding cartilage. A cell surface marker that
defines FLS is CD55. The presence of CD55 in the intimal lining
was initially reported by Medof et al. [5]. Later work by Stevens et
al. and Edwards and Wilkinson identified CD55 as a marker with
an apparent specificity for intimal fibroblasts in synovial disease
[6,7].
CD55, also known as decay-accelerating factor (DAF), is
a broadly expressed cell surface molecule that protects cells from
self-inflicted damage mediated by complement activation. CD55
controls complement by accelerating the decay of C3/C5
convertases [8]. In line with this well-established function,
CD55-deficient mice develop increased complement-mediated
autoimmunity in a variety of antibody-driven models [9]. Next to
its role as a complement regulator, CD55 is a binding partner of
CD97, an adhesion-type G protein-coupled receptor (GPCR)
abundantly expressed on almost all leukocytes [10–13]. Adhesion-
GPCRs are nonclassical heptahelical receptors that facilitate cell
and matrix interactions of various cell types [14]. CD97-positive
macrophages closely associate with CD55-expressing FLS in the
synovial intima [15]. Using CD97-specific multivalent fluorescent
probes, we previously demonstrated the ability of CD97 to interact
with CD55 on FLS in RA synovium [16]. Based on the site-
specific expression of CD55 and CD97, and the finding that CD97
facilitates leukocyte adhesion in vitro [11], we postulated that the
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+ intimal macrophages with CD55
+ FLS
might facilitate the accumulation of inflammatory cells in the
synovial tissue of RA patients. Using gene-deficient mice, we
recently demonstrated that lack of both CD55 and CD97 indeed
ameliorates disease activity in collagen-induced and K/BxN serum
transfer models of RA [17].
The high and cell type-specific expression of CD55 raises the
question how CD55 expression is triggered in FLS. FLS can be
activated by cytokines and molecular patterns, originating from
damaged cells, present in the synovial fluid [2–4]. We therefore
tested the ability of a range of pro-inflammatory cytokines and
Toll-like receptor (TLR) ligands to induce CD55 expression in
cultured FLS. We show that CD55 was strongly upregulated by
triggering of TLR3, an endosomal pattern recognition receptor
involved in the detection of double-stranded (ds)RNA. Stimulation
of the cytoplasmic dsRNA sensors melanoma differentiation-
associated gene 5 (MDA5) and retinoic acid-inducible gene-I
(RIG-I) induced CD55 expression as well. Notably, activation of
MDA5, but hardly TLR3 or RIG-I triggering, caused cell death in
cultured FLS. Finally, we show that TLR3 activation enhanced
the binding of CD97-loaded beads in FLS in a CD55-dependent
manner, suggesting that dsRNA increases the interaction of FLS
with CD97-positive leukocytes.
Materials and Methods
Isolation and Culture of FLS and Dermal Fibroblasts
Synovial tissue samples were obtained by needle arthroscopy
from patients with different forms of arthritis [18]. RA patients
fulfilled the American College of Rheumatology (ACR) criteria
[19], non-psoriatic spondylarthritis (SpA) patients fulfilled Euro-
pean Spondylarthropathy Study Group (ESSG) criteria [20],
patients with psoriatic arthritis (PsA) fulfilled the Classification
Criteria of Psoriatic Arthritis (CASPAR) study group criteria [21],
and patients with inflammatory osteoarthritis (OA) fulfilled
established criteria [22] and had a joint effusion in the absence
of rheumatic disease other than OA. Clinical data on patients and
medication are presented in Table 1. The study was approved by
the Medical Ethics Committee of the Academic Medical Center,
and all patients gave written informed consent.
Single cell suspensions were generated by finely mincing freshly
isolated synovial tissue, followed by treatment with 0.5 mg/ml
collagenase type VIII (Sigma-Aldrich, Zwijndrecht, The Nether-
lands) for 2 h at 37uC. The obtained cell suspension was cultured
in Dulbecco’s Eagle’s medium (DMEM; 1 g/l D-glucose)
supplemented with 10% heat inactivated fetal calf serum (FCS),
L-glutamine, HEPES, and antibiotics (penicillin, gentamicin, and
streptomycin) (Gibco, Breda, The Netherlands). Non-adherent
cells were removed after 24 h, and adhering cells were grown to
sub-confluence (80%) and subsequently split (1:3) by trypsiniza-
tion. Synovial fibroblasts were used for experiments from passage
3 until passage 9; at that time cultures were free of macrophages
and non-fibroblasts.
Primary dermal fibroblasts, obtained from biopsy samples of
normal skin, were kindly provided by Dr. Marcel Teunissen
(AMC, Amsterdam, The Netherlands). The cells were cultured in
Ham’s F-12 medium (Gibco) with 10% FCS and used for
experiments between passage 3 and 5.
Reagents and Stimulation Assays
Synovial and dermal fibroblasts were cultured in 6-well plates
and allowed to grow to 70–90% confluence. After serum
starvation over night in DMEM containing 1% FCS, the cells
were stimulated for 48 h with the following agents: tumor necrosis
factor a (TNFa; 100 ng/ml; BioSource International, Camarillo,
CA, USA), interferon a (IFNa2a; 100 or 1000 U/ml; PBL
Biomedical Laboratories, Piscataway, NJ, USA), IFNb (100 or
1000 U/ml; Peprotech, Rocky Hill, NJ, USA), interleukin 1b (IL-
1b; 100 ng/ml), IL-6 (1 ng/ml) (both Invitrogen, Breda, The
Netherlands), IFNc (100 ng/ml), lipoteichoic acid from Staphylo-
coccus aureus (LTA; 100 mg/ml), polyinosinic-polycytidylic acid
(poly(I:C); from 0.01–250 mg/ml), lipopolysaccharide from Escher-
ichia coli K-235 (LPS; 10 mg/ml), imiquimod (100 mg/ml) (all
Sigma-Aldrich), and CpG oligonucleotides (10 mg/ml; Invivogen,
San Diego, CA, USA). When indicated, hydroxychloroquine
(HCQ; 2–5 mg/ml; Sigma-Aldrich) was added to the cultures 2 h
prior to stimulation with poly(I:C). For intracellular delivery of
poly(I:C) and 59-triphosphate RNA (3pRNA; kindly provided by
Prof. G. Hartmann and Dr. M. Schlee, University Hospital Bonn,
Germany) transfection reagent Fugene HD (Roche, Mannheim,
Germany) was used according to the manufacturer’s protocol.
Flow Cytometry
For measurement of CD55, CD46, and CD59 surface
expression, FLS were detached from 12-well plates with
TrypLE
TM (Gibco), washed with PBS/0.5% bovine serum
albumine (BSA), and incubated for 30 min at 4uC with the
following monoclonal antibodies: CD55-APC (1:50; BD Bios-
Table 1. Clinical features and treatment of RA, OA, PsA, and SpA patients included in the study.
RA patients n=12 OA patients n=5 PsA patients n=4 SpA patients n=5
Sex, no. males/females 2/10 2/3 4/0 1/4
Age, years median (range) 62 (49–80) 63 (50–67) 41 (36–54) 41 (33–57)
DoD, months median (range) 90 (2–414) 24 (12–100) 85 (2–180) 288 (0–384)
IgM-RF, no. positive/negative 9/3 n/a n/a 5/0
ACPA, no. positive/negative 11/1 n/a n/a 5/0
No medication, no. 0 3 2 2
NSAIDs, no. 8 2 2 0
MTX, no. 11 0 0 3
DMARDs, no. 7 0 0 2
No = number of patients; DoD = duration of disease; IgM-RF = immunoglobulin M-rheumatoid factor; ACPA = anti-citrullinated peptide antibodies; MTX =
Methotrexate; NSAIDs = non-steroidal anti-inflammatory drugs; DMARDs: disease-modifying anti-rheumatic drugs; n/a = not available.
doi:10.1371/journal.pone.0035606.t001
CD55 Expression on Synovial Fibroblasts
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Raleigh, NC, USA), and CD59-PE (1:100; eBiosciences, San
Diego, CA, USA) or isotype control antibodies: IgG2a-APC
(1:50), IgG1-FITC (1:50), and IgG2a-PE (1:100) (all BD, Breda,
The Netherlands).
To study the expression and accessibility of particular short
consensus repeats (SCR) of CD55, cells were incubated with
monoclonal antibodies LA1 (anti-SCR1), LA2 (anti-SCR3), LA4
(anti-SCR4), LA5 (anti-stalk) (all kindly provided by Prof. Lucien
Aarden, Sanquin Research, Amsterdam, The Netherlands), and
BRIC110 (anti-SCR2; IBGRL, Filton, Bristol, UK) or with control
mouse IgG (all 5 mg/ml). After washing, cells were incubated with
APC-labeled goat-anti-mouse antibody (1:300; BD Biosciences).
Figure 1. Expression of complement regulatory proteins on cultured FLS of patients with different forms of arthritis. CD55, CD46, and
CD59 expression was measured by flow cytometry on cultured FLS from patients with RA, OA, PsA, and SpA. Indicated is the fold difference in mean
fluorescence intensity (MFI) over respective isotype control Ig (cMFI) (mean, n=425).
doi:10.1371/journal.pone.0035606.g001
Figure 2. CD55 is upregulated by poly(I:C) and IL-1b on synovial fibroblasts. RA-derived synovial fibroblasts (A, C-F) and dermal fibroblasts
(B) were starved overnight and subsequently stimulated for 2 days with 100 ng/ml TNFa, 100 ng/ml IFNc, 100 ng/ml IL-1b, 1 ng/ml IL-6, 100 U/ml
IFNa, 100 mg/ml LTA (TLR2 ligand), 100 mg/ml poly(I:C) (TLR3 ligand), 10 mg/ml LPS (TLR4 ligand), 100 mg/ml imiquimod (TLR7 ligand), or 10 mg/ml
CpG oligonucleotides (TLR9 ligand). Expression of CD55 (A and B), CD46 (C) and CD59 (D) was studied by flow cytometry. E, Upregulation of CD55 in
response to increasing concentrations of poly(I:C). F, Inhibition of CD55 upregulation by chloroquine (HCQ), an inhibitor of endosomal acidification,
added prior to poly(I:C) stimulation. Indicated is the relative protein expression as percentage of the medium control (mean 6 SD, n=6 (A) and 3–5
(B-F)). *, p,0.05; **, p,0.005.
doi:10.1371/journal.pone.0035606.g002
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FITC (1:100; IQ Products, Groningen, The Netherlands) for
30 min at 4uC in calcium buffer. Before measurement, propidium
iodide (5 ng/ml; Sigma) was added.
All stainings were visualized by flow cytometry on a FACSCa-
libur (Becton Dickinson, San Jose, CA, USA), and results were
analyzed using the FlowJo software package (Tree Stars, Ashland,
OR, USA).
Quantitative and Semi-quantitative PCR
FLS were detached from 6-wells plates as described above, and
RNA was isolated using the Invisorb spin cell RNA mini kit
(Westburg, Leusden, The Netherlands). RNA quantity and purity
was measured on a NanoDrop (ND-1000; NanoDrop Technol-
ogies, Rockland, DE, USA). Reverse transcription was performed
with random hexamer primer and SuperScript II RNase H-
reverse transcriptase kit (Invitrogen) according to manufacturer’s
protocol. Transcript levels of dsRNA sensors (TLR3, MDA5,
RIG-I) were analyzed by quantitative PCR with the StepOnePlus
Real-Time PCR system using Fast SYBRH Green Master Mix
(Applied Biosystems, Carlsbad, CA, USA). Gene transcription was
normalized to 18S rRNA (DCt). The relative expression ratios
were calculated using the 2
2DDCt method. Transcript levels of
cytokines (IFNb, IP10, TNFa) were analyzed by semi-quantitative
PCR using Salsa polymerase (MRC Holland, Amsterdam, The
Netherlands) and the Bio-Rad C1000 Thermal cycler (Bio-Rad
laboratories, Veenendaal, The Netherlands). PCR products were
visualized in agarose gels. Primer sequences and annealing
temperatures for all PCRs are depicted in Table S1.
CD97-binding Assay
Cell-binding assays using biotinylated Fc-proteins coupled to
fluorescent beads were performed as described previously [23].
Briefly, 10 ml avidin-coated fluorescent beads (Spherotech,
Libertyville, IL, USA) were washed and incubated with saturating
amounts (.1 mg) of biotinylated recombinant protein (CD97-
3EGF or EMR2-2EGF; kindly provided by Organon-Schering
Plough, Cambridge, MA). After 1 h, non-binding protein was
removed, and the bead-protein complexes were sonicated
immediately before addition to poly(I:C)-stimulated or unstimu-
lated FLS for 1 h. For blocking studies, cells were preincubated for
30 min with CLB-CD97L/1 ascitis (1:2000, anti-CD55). Adher-
ence of beads to the cells was analyzed by flow cytometry
(FACSCalibur).
Statistical Analysis
Statistical analyses were performed in SPSS (version 16.0; SPSS,
Chicago, IL, USA) and Graph Pad Prism (version 5; GraphPad
software, La Jolla, CA, USA). Protein expression, mRNA levels
and amount of apoptotic cells on stimulated synovial fibroblasts
were compared to unstimulated cells with two-tailed paired T-test.
Expression on synovial fibroblasts of different arthritides was
compared using two-tailed Mann Whitney U tests. A two-tailed
unpaired T-test was used to compare the levels of fluorescent bead
binding.
Results
Cultured FLS Express the Complement Regulators CD55,
CD46, and CD59
We studied the expression levels of CD55 on FLS from patients
with different forms of arthritis by flow-cytometric analysis. CD55
expression levels did not differ between cells from RA, OA, PsA, or
SpA (Figure 1A). We also analyzed the expression levels of CD46
and CD59, two other established complement regulators, but
found no differences between FLS of different arthritides
(Figure 1B and C).
Poly(I:C) Induces CD55 Expression on FLS through TLR3
To address the regulation of CD55 in FLS, we stimulated cells
with various inflammatory cytokines and TLR ligands. IL-1b and
especially poly(I:C) significantly enhanced CD55 expression in
FLS from RA (Figure 2A, Figure S1) and OA (data not shown). In
contrast, CD55 was not upregulated in dermal fibroblasts by any
of the tested stimuli (Figure 2B). Moreover, we did not observe
induction of CD46 and CD59 in stimulated RA FLS (Figure 2C
and D), suggesting specific regulation of CD55 expression in FLS.
Poly(I:C) is an analog for dsRNA of viral origin that dose-
dependently induced expression of CD55 on protein (Figure 2E)
and mRNA level (data not shown). A specific sensor for poly(I:C)
Figure 3. FLS express functional cytoplasmic dsRNA sensors. RA-derived synovial fibroblasts were stimulated for 16 h with the indicated
concentrations (mg/ml) of poly(I:C), poly(I:C) with fugene, or 3pRNA with fugene to trigger, respectively, TLR3, MDA5, and RIG-I. Transcription levels of
(A) TLR3, MDA5, and RIG-I, and (B) the anti-viral/pro-inflammatory response genes IFN b, IP-10, and TNFa was measured by quantitative and
semiquantitative PCR, respectively. Depicted is the fold change gene expression compared to medium control (mean 6 SD, n=4) (A)o r
representative photographs (B). *, p,0.05, **, p,0.005.
doi:10.1371/journal.pone.0035606.g003
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Chloroquine (HCQ) inhibits endosomal acidification, thereby
preventing TLR3 signaling. We found that chloroquine reduced
the upregulation of CD55 (Figure 2F), implying that poly(I:C)-
induced CD55 expression was mediated by TLR3. Complete
inhibition was not accomplished, since the inhibitor was toxic to
cultured FLS at concentrations above 5 mg/ml (data not shown).
TLR3 is known to mediate the production of type I IFNs, which
subsequently, upon binding to the IFNa/a ˆ receptor, can turn on
the transcription of a large set of interferon-stimulated genes
(ISGs). To test whether type I IFNs regulate CD55 expression, we
stimulated FLS with IFNa and IFNb. Even at high concentrations
of 1000 U/ml, expression levels of CD55 were hardly affected
(data not shown), indicating that signaling through type I IFN
receptors is not sufficient to induce CD55 expression in RA-FLS.
Stimulation of the Cytoplasmic dsRNA Receptors MDA5
and RIG-I in FLS Causes CD55 Upregulation and, through
MDA5, Cell Death
In addition to TLR3, most cell types express the cytoplasmic
helicases MDA5 and RIG-I, which sense dsRNA formed during
viral replication in infected cells [24]. Activation of MDA5 and
RIG-I can be accomplished in vitro by transfection of the dsRNA
analogs poly(I:C) and 3pRNA, respectively. The expression of
TLR3, MDA5, and RIG-I was analyzed in FLS stimulated with
these dsRNA mimics, since it is known that receptors expression
can be induced by their ligands [25–27]. Figure 3A shows that
both extra- and intracellular stimulation with poly(I:C) and
intracellular stimulation with 3pRNA upregulated transcription
of TLR3, MDA5, and RIG-I. Moreover, activation with dsRNA
induced transcription of the anti-viral and pro-inflammatory
response genes IFNb, IP-10 (CXCL10), and TNFa (Figure 3B).
Thus, FLS are equipped with functional endosomal and cytoplas-
mic dsRNA sensors.
Next, we tested whether triggering of MDA5 and RIG-I would
promote CD55 expression, like TLR3 signaling does. Protein
levels of CD55 were indeed elevated in FLS after stimulation of
MDA5 or RIG-I (Figure 4A). Notably, transfection with poly(I:C)
already at the intermediate concentration of 0.1 mg/ml induced
significant cell death. After transfection of 1 mg/ml poly(I:C),
about 60% of cells died, whereas high concentrations of
extracellular poly(I:C) and 3pRNA caused death in up to 20%
Figure 4. Stimulation of cytoplasmic dsRNA receptors in FLS upregulates CD55 expression and, through MDA5, induces cell death.
RA-derived synovial fibroblasts were stimulated for 2 days with the indicated concentrations (mg/ml) of poly(I:C), poly(I:C) with fugene, or 3pRNA with
fugene to trigger, respectively, TLR3, MDA5, and RIG-I. A, Expression of CD55 analyzed by flow cytometry (mean 6 SD, n=6). B, Representative flow
cytometry plots of annexin V and propidium iodide staining. C, Percentages of annexin V and/or propidium iodide-positive cells analyzed by flow
cytometry (mean 6 SD, n=6). D, E, Effect of the pan-caspase inhibitor QVD on cell death and CD55 expression induced by intracellular delivery of
poly(I:C) (mean 6 SD, n=3). *, p,0.05; **, p,0.005; ***, p,0.001.
doi:10.1371/journal.pone.0035606.g004
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inhibitor QVD reduced cell death at a concentration of poly(I:C)
of 1 mg/ml, but had no effect at 0.1 mg/ml, indicating that
MDA5-induced cell death in cultured FLS is partially caspase-
dependent (Figure 4D). CD55 induction was not influenced by
QVD treatment (Figure 4E). We concluded that activation of
cytoplasmic dsRNA receptors not only promoted the expression of
CD55, but MDA5 signaling also caused cell death in cultured
FLS.
Upregulation of CD55 on FLS Increases the Binding
Capacity for CD97
CD55 interacts with CD97 by binding of the SCRs 1, 2, and 3
of the adhesion-GPCR [11,13]. To study whether synovial
fibroblasts of arthritis patients express the CD55 domains involved
in CD97 binding, we stained the cells with antibodies recognizing
individual SCRs. Flow-cytometric analysis confirmed that FLS of
RA, OA, SpA, and PsA patients express full-length CD55
possessing all four SCRs (Figure S2).
We then tested whether induction of CD55 on RA-derived FLS
enhanced their binding capacity for CD97 by incubating the cells
with fluorescent CD97-loaded beads. Indeed, we observed
a significant increase in binding of CD97-loaded beads after
TLR3-mediated CD55 upregulation, which was blocked entirely
by antibodies against CD55 (Figure 5).
Discussion
We here show that cultured FLS derived from RA patients
express CD55 and that the amount of membrane-bound CD55 is
increased by the triggering of dsRNA sensors in these cells. We
demonstrate that CD55 induction enhanced the binding of CD97-
loaded beads to RA-derived FLS, suggesting that dsRNA
promotes the interaction of FLS with CD97-bearing leukocytes.
Finally, we report that stimulation of the cytoplasmic dsRNA
receptor MDA5 initiates cell death in cultured FLS.
CD55 is an established histological marker for FLS in the
intimal lining layer of the synovium in arthritis patients [3,15]. We
previously demonstrated that immunohistochemical staining for
CD55 in the intimal lining layer tends to be higher in RA as
compared to OA [15]. Currently, it is not known how CD55
expression is regulated in FLS. In other cell types, expression of
CD55 is enhanced by cytokines such as TNFa [28,29], which are
highly present in the synovium of RA patients [30]. We observed
that in cultured RA FLS, CD55 was not induced by TNFa, yet the
pro-inflammatory cytokine IL-1b enhanced its expression by
about two-fold. Others have demonstrated that IL-1b also
promotes CD55 expression in articular chondrocytes, hepatoma
cells, and intestinal epithelial cells [31–33]. In contrast to some of
these cell types [31,33], expression of two other complement
regulators (CD46 and CD59) was not enhanced by pro-
inflammatory cytokines in cultured RA FLS. Furthermore, we
observed that none of the tested cytokines or TLR ligands
enhanced CD55 expression in dermal fibroblasts, which express
functional TLRs [34]. Thus, selective regulation of CD55
expression in FLS is specific for this cell type.
Activation of the dsRNA sensors TLR3, MDA5, and RIG-I
robustly enhanced the expression of CD55 in FLS in a dose-
dependent manner. Previous studies have shown that FLS express
TLR3, MDA5, and RIG-I [35–39]. Moreover, these studies
demonstrated that TLR3 and RIG-I triggering induces the
expression of type I IFNs, cytokines, chemokines, and matrix
metalloproteinases and proved activation of the transcription
factors activator protein 1 (AP-1), NF-kB, and interferon-
regulating factor (IRF) 3 and 7, which are crucially involved in
dsRNA sensor-mediated gene expression [24]. We here confirm
and extend these findings, and show that also MDA-5 is functional
in cultured FLS. In agreement with the well-known ability of
dsRNA sensors to induce their own expression [25–27], we found
that transcription levels of TLR3, MDA5, and RIG-I in cultured
RA FLS were upregulated in response to any form of stimulation
with dsRNAs. Moreover, triggering of TLR3, MDA5, and RIG-I
induced the expression of IFNb, IP-10, TNFa, and, as shown here,
CD55, further demonstrating the functionality of these signaling
paths in synovial fibroblasts. The inability of pro-inflammatory
cytokines and synovial fluid (data not shown) to upregulate CD55
suggests that CD55 expression is regulated rather by IRF3 and/or
IRF7 than by NF-kB or AP-1. IRFs are known to induce the
production of type I IFNs, which in turn can trigger interferon-
stimulated genes (ISGs) after binding to the IFNa/b receptor.
However, IFNa and IFNb did not induce CD55 expression,
indicating that dsRNA-induced CD55 upregulation is not the
result of a type I IFN feed-forward loop.
Figure 5. Poly(I:C)-induced upregulation of CD55 on synovial
fibroblasts increases the binding capacity for CD97. Synovial
fibroblasts were stimulated for 2 days with 100 mg/ml poly(I:C). Affinity
for CD97 was measured with multivalent fluorescent probes loaded
with recombinant CD97-3EGF or EMR2-2EGF (control). To confirm
specificity, cells were preincubated with mAb CLB-CD97L/1, directed
against the first SCR of CD55. On top, representative histogram plots are
shown. The bars represent the fold difference in mean fluorescence
intensity (MFI) for CD97-3EGF over EMR2-2EGF (mean 6 SD, n=3). *,
p,0.05.
doi:10.1371/journal.pone.0035606.g005
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intracellularly delivered poly(I:C) initiates cell death in cultured
FLS. Recent studies have shown that dsRNA receptor activation
can promote apoptosis in malignant cells [40–43]. In many non-
malignant cells, dsRNA is not inducing cell death directly but can
activate a pro-apoptotic program that renders cells susceptible to
other apoptotic stimuli [42–45]. We observed that in cultured RA
FLS, activation of MDA5 directly induced cell death, which was
only partly caspase-dependent. It is known that triggering of
MDA5 can induce expression of the pro-apoptotic BH3-only
protein Noxa, leading to activation of the mitochondrial apoptosis
pathway [27,42,45,46]. Notably, another pro-apoptotic BH3-only
protein, Puma, has been identified as a rapid and potent inducer of
apoptosis in FLS [47] and can be induced by dsRNA sensor
activation as well [27,42,45]. Others found that MDA5 triggering
induces autophagy and death in melanoma cells [44]. Whether the
same mechanisms play a role in FLS remains to be identified. In
addition, it needs to be investigated whether the initiation of cell
death upon MDA5 triggering relates to the neoplastic phenotype
that has been described for FLS in RA [3]. Beyond the initial
scope of our study, the observation that triggering of MDA5
effectively induces death in synovial fibroblasts, raises the
possibility that MDA5 might be a therapeutic target for the
reduction of intimal hyperplasia in RA.
An important question relates to the possible source of the
stimuli that trigger CD55 expression in cultured FLS. IL-1b is
a critical cytokine in autoinflammatory diseases that is released
upon caspase-1-dependent and independent processing [48].
Moreover, both IL-1b and dsRNA become available during viral
infection [24]. While dsRNA represents the genome of some
viruses and is an intermediate formed by many viruses during their
replication, the role of viruses in the etiology and pathology of RA
is uncertain [49–51]. Next to viral dsRNA, TLR3 has been shown
to recognize endogenous RNA released from necrotic cells [35,52–
54]; however, our attempts to induce CD55 with either synovial
fluid or necrotic FLS failed (data not shown). Interestingly,
extracellular RNA is abundantly present in the synovial lining
[55], and it remains to be shown whether chemical modifications
that protect endogenous RNAs from enzymatic degradation can
generate de novo ligands that are able trigger dsRNA sensors in
FLS. In line herewith, recent evidence suggests that RIG-I-like
helicases are modifiers of sterile inflammation in the mouse colon
and brain [56,57].
Together, our data indicate that inflammatory and viral cues in
synovial tissue may upregulate CD55 on FLS, which can facilitate
the interaction with CD97
+ leukocytes. As growing evidence
suggests that CD55 is part of the stromal address code that directs
the retention and survival of inflammatory immune cells in the
synovium [16,58], it will be important to study the expression of
CD55 in early arthritis and in various forms of established
arthritis.
Supporting Information
Figure S1 CD55 is upregulated by IL-1b and poly(I:C) on
synovial fibroblasts. RA derived synovial fibroblasts were
stimulated for two days with 100 ng/ml IL1b or 100 mg/ml
poly(I:C). CD55 expression on synovial fibroblasts was analysed by
flow cytometry. Representative scatter plot and histograms are
shown.
(TIF)
Figure S2 Synovial fibroblasts express full-length CD55.
Synovial fibroblasts of rheumatoid arthritis (RA), osteoarthritis
(OA), psoriatic arthritis (PsA), and spondyloarthritis (SpA) patients
were analyzed by flow cytometry with domain-specific antibodies
recognizing either the stalk or individual short consensus repeats
(SCR) 1 to 4 and the stalk region of CD55. Representative
histograms of 3 experiments are shown.
(TIF)
Table S1 PCR primer specification.
(TIF)
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